Business Description
Hisamitsu Pharmaceutical Co Inc
ISIN : JP3784600003
Share Class Description:
FSE:4530: Ordinary SharesTotal Employee Number:
3,697Compare
Compare
Traded in other countries / regions
4530.JapanHPX.GermanyHTSUY.USA IPO Date
1962-09-01Description
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 49.95 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.08 | |||||
Interest Coverage | 853.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.74 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.2 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 22.7 | |||||
3-Year FCF Growth Rate | 29.6 | |||||
3-Year Book Growth Rate | 7.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.23 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.04 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -5.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.08 | |||||
Quick Ratio | 3.57 | |||||
Cash Ratio | 2.35 | |||||
Days Inventory | 135.33 | |||||
Days Sales Outstanding | 111.5 | |||||
Days Payable | 57.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.17 | |||||
3-Year Dividend Growth Rate | -18.8 | |||||
3-Year Average Share Buyback Ratio | 3.3 | |||||
Shareholder Yield % | -0.23 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.96 | |||||
Operating Margin % | 10.99 | |||||
Net Margin % | 11.75 | |||||
EBITDA Margin % | 18.85 | |||||
FCF Margin % | 5.78 | |||||
OCF Margin % | 10.72 | |||||
ROE % | 6.97 | |||||
ROA % | 5.56 | |||||
ROIC % | 7.03 | |||||
3-Year ROIIC % | 9.31 | |||||
ROC (Joel Greenblatt) % | 25.4 | |||||
ROCE % | 8.01 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.8 | |||||
Forward PE Ratio | 13.59 | |||||
PE Ratio without NRI | 14.61 | |||||
Shiller PE Ratio | 18.23 | |||||
PEG Ratio | 0.72 | |||||
PS Ratio | 1.76 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 0.98 | |||||
Price-to-Free-Cash-Flow | 30.08 | |||||
Price-to-Operating-Cash-Flow | 16.23 | |||||
EV-to-EBIT | 13.17 | |||||
EV-to-EBITDA | 10.15 | |||||
EV-to-Revenue | 1.91 | |||||
EV-to-FCF | 33.08 | |||||
Price-to-GF-Value | 1.23 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-Median-PS-Value | 0.59 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.63 | |||||
Price-to-Graham-Number | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 2.14 | |||||
| Price-to-Net-Cash | 6.46 | |||||
Earnings Yield (Greenblatt) % | 7.59 | |||||
FCF Yield % | 2.22 | |||||
Forward Rate of Return (Yacktman) % | 22.25 |
Hisamitsu Pharmaceutical Co Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hisamitsu Pharmaceutical Co Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| 0.0000000426:1 Stock Split | 2026-05-11 | 3,975.00 (+0.00%) | ||
| JPY 15.000000 Cash Dividend | 2025-08-28 | 3,975.00 (+0.00%) | ||
| JPY 45.000000 Cash Dividend | 2025-08-28 | 3,975.00 (+0.00%) | ||
| JPY 2.000000 Cash Dividend | 2025-02-27 | 4,215.00 (+0.00%) | ||
| JPY 43.000000 Cash Dividend | 2025-02-27 | 4,215.00 (+0.00%) | ||
| JPY 2.000000 Cash Dividend | 2024-08-29 | 4,215.00 (+0.00%) | ||
| JPY 43.000000 Cash Dividend | 2024-08-29 | 4,215.00 (+0.00%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hisamitsu Pharmaceutical Co Inc
No articles.